Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

SHOCKING: Rklb - You Need To See This

MarketBeat Week in Review – 06/01 - 06/05

Stocks sold off sharply to end the week with money moving out of technology stocks and into many of the Dow components; inflation fears are rising.

MarketBeat

Rocket Lab Stock Is Up 330% Over the Past Year. The SpaceX IPO Threatens to Rock the Boat.

Rocket Lab’s incredible rally has made it a space stock favorite, but SpaceX’s blockbuster IPO could steal the spotlight.

Barchart

Rocket Lab Is Down 24% From Its 52-Week High—Pullback or Problem?

Rocket Lab's 18% pullback from its 52-week high appears to reflect normal consolidation rather than any deterioration in business fundamentals.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Despite Positive Developments, Rocket Lab Stock Is a High-Risk Name

Rocket Lab is having trouble with a key rocket.

Barchart

Will the SpaceX IPO Put These 5 Public Space Stocks Into a Higher Orbit?

With SpaceX targeting a Nasdaq listing as early as June 12 at a $1.75-$2 trillion valuation, five stocks—Rocket Lab, Alphabet, Redwire, Intuitive Machines, and Destiny Tech100—offer the strongest operational or financial ties to the IPO.

MarketBeat

MarketBeat Week in Review – 05/25 - 05/29

Stocks made a strong rally with tech stocks leading the way; investors also eyed a potential extension to the ceasefire between the U.S. and Iran

MarketBeat

Rocket Lab Keeps Making Headlines and Highs—Here's What's Driving the Latest Move

Rocket Lab has gained major momentum in recent days driven by a $90 million Space Force contract, the Motiv Space Systems acquisition, and SpaceX's $2 trillion IPO filing.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

The $90 Million Reason Rocket Lab Is Flying Higher Today

Rocket Lab stock rallies on a $90 million U.S. Space Force contract. But does that warrant buying RKLB shares at current levels?

Barchart

Rocket Lab Stock Is Getting a Major Lift. Investors Are Betting on Its Neutron Launch Later This Year.

Rocket Lab stock is blasting higher as investors bet on the growing demand for Neutron launches, which could position it as a serious competitor in the medium-lift rocket market.

Barchart

Rocket Lab Just Hit a New All-Time High—Time to Buy or Let It Breathe?

Rocket Lab surged over 40% in two trading sessions following its Q1 earnings report, closing at a new all-time high of $117.35 on Tuesday and pushing its YTD gain to 68%.

MarketBeat

Will the SpaceX IPO Take Tema’s Space ETF (NASA) to the Moon?

Space is the next frontier, but there’s also a lot of “space junk” masquerading as high-quality investment merchandise.

Barchart

The Space Race Just Hit a Bottleneck—Who Benefits?

Blue Origin's grounding of New Glenn after an April 19 mishap tightens an already-constrained launch market, potentially benefiting RKLB, FLY, and LUNR.

MarketBeat

If There's a Domestic Manufacturing Boom, These 3 Stocks Could Win

A domestic manufacturing surge might still be on the horizon, and these three companies representing different industries could benefit.

MarketBeat

SpaceX IPO Frenzy: 3 Space Stocks That Could Benefit Most

The SpaceX IPO is coming. Discover three space stocks positioned to benefit as investor interest in the commercial space economy accelerates

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

MarketBeat Week in Review – 04/13 - 04/17

Stocks surged after Iran announced the Strait of Hormuz was open for commercial shipping; a sustained rally may create an opportunity in beaten-down stocks

MarketBeat

Rocket Lab Is Back at a Line in the Sand—Now What?

Rocket Lab has reclaimed its 50- and 20-day SMAs above the key $65 support level, with a move above $78 potentially signaling a higher-timeframe breakout.

Barchart

Looking to Profit From the Artemis II Mission? Buy RocketLab and AeroVironment Stocks.

Artemis II has sparked fresh investor interest in space. Rocket Lab and AeroVironment emerge as solid next-gen stocks to buy in an evolving defense and space market.

MarketBeat

Rocket Lab Gets Approval to Acquire Mynaric: Why This Matters

Rocket Lab has received regulatory approval to acquire Mynaric, a laser-optical communications specialist, with the deal expected to close in April.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Why EchoStar and Rocket Lab Stocks Could Be Top Buys Ahead of a SpaceX IPO

EchoStar holds SpaceX equity rights worth up to $11 billion. Rocket Lab posted record revenue of $602 million. Here's why both stocks could rally ahead of a SpaceX IPO.

Barchart

Out-of-This-World Options: 3 Larger, Diverse Spread Trades in Rocket Lab Stock

Rocket Lab is an emerging bet on the space industry, and options traders are clearly taking notice.

Barchart

Does Rocket Lab's $2 Billion Backlog Offset Dilution Concerns?

Rocket Lab’s $190 million hypersonic contract has propelled its backlog beyond $2 billion, capping a busy week that also included an equity raise announcement. Investors need to balance explosive contract growth against fresh dilution pressures.

Barchart

How Is Textron's Stock Performance Compared to Other Aerospace & Defense Stocks?

Textron has underperformed other aerospace & defense stocks over the past year, yet analysts remain somewhat optimistic about the stock’s outlook.

MarketBeat

Rocket Lab Finds Its Footing as Post-Earnings Support Takes Shape

Rocket Lab is stabilizing after an almost 30% pullback from record-highs, with shares holding key support and potentially forming a higher low.

MarketBeat

RKLB Delivers Record Results, But Neutron Delay Weighs on Shares

Rocket Lab (NASDAQ: RKLB) posted record revenue in 2025, expanded margins, and a $1.85 billion backlog, with strong near-term visibility.

MarketBeat

Rocket Lab Earnings Loom as Neutron Timeline Takes Center Stage

Rocket Lab (NASDAQ: RKLB) shares have pulled back nearly 30% from their highs ahead of a pivotal fourth-quarter earnings report.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.